HeyJaredHibah Khaja
- Indexed articles, last 90 days
- 101
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Endocrinology Advisor
- Top 5M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
GLP-1 Linked to Lower Mortality and Cardiovascular Risk in Serious Mental Illness (opens the original)
Read excerpt
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce mortality and cardiovascular risk among adults with serious mental illness (SMI), according to study findings published in JAMA Psychiatry. Researchers conducted a retrospective target trial emulation that aimed to determine whether initiation of GLP-1 RAs vs sodium-glucose cotransporter-2 (SGLT2) inhibitors was associated with differences in mortality and cardiovascular outcomes. Using electronic health record (EHR) data from th
GLP-1 Linked to Lower Mortality and Cardiovascular Risk in Serious Mental Illness (opens the original)
Read excerpt
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce mortality and cardiovascular risk among adults with serious mental illness (SMI), according to study findings published in JAMA Psychiatry. Researchers conducted a retrospective target trial emulation that aimed to determine whether initiation of GLP-1 RAs vs sodium-glucose cotransporter-2 (SGLT2) inhibitors was associated with differences in mortality and cardiovascular outcomes. Using electronic health record (EHR) data from th
Neuronal Antibodies Rarely Found in Atypical Parkinsonism (opens the original)
Read excerpt
Neuronal antibody-associated disorders are uncommon among patients with atypical parkinsonism (AP) who undergo antibody testing, according to study results published in Neurology: Neuroimmunology & Neuroinflammation. Some antibody-associated neurologic disorders can develop gradually and without inflammatory findings typically associated with autoimmune disease, potentially resembling neurodegenerative conditions. Anti-IgLON5 disease, in particular, can produce manifestations that overlap with p
Dementia Linked to Greater Care Needs Among Older Adults in China (opens the original)
Read excerpt
Dementia is associated with markedly greater care requirements among middle-aged and older adults in China, despite no corresponding increase in health care utilization. These study findings were published in The Journal of Prevention of Alzheimer’s Disease. Previous estimates of dementia prevalence in China have varied considerably, and nationally representative evidence is particularly limited for adults younger than 65 years. Less is also known about how dementia affects health care use and t
Disparity in Anti-Amyloid Eligibility Seen in Atypical Alzheimer Disease (opens the original)
Read excerpt
Most patients with atypical Alzheimer disease (AD) do not qualify for anti-amyloid therapy under current eligibility frameworks, according to study findings published in Neurology. Anti-amyloid therapy trials have largely enrolled patients with early, memory-predominant AD. Researchers therefore examined how frequently patients with atypical AD presentations would qualify under eligibility criteria from the CLARITY-AD (ClinicalTrials.gov Identifier: NCT03887455) and TRAILBLAZER-ALZ2 (ClinicalTri
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Endocrinology Advisor, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.